VLX Ventures
Pre-seed → Series B
Their stated focus (public profile)
VLX Ventures focuses on biopharma therapeutic ventures developing drugs for challenging diseases, as well as digital pharma ventures combining deep biology with computational biology for precision medicine and diagnostics. The firm identifies cutting-edge technologies, conducts intensive R&D and business validation, establishes startups, recruits teams, and invests in and accelerates their growth. Their portfolio spans companies from early pre-clinical to Phase 3 advanced clinical studies.
Stages: Pre-seed → Series B
Sectors: Life sciences, Computational biology, Multiomics, Medtech
Website: vlx.co.il
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.